TickerTry: NVDA · AAPL · PLTR · NFLX
NASDAQ · Healthcare · Biotechnology

Lyell Immunopharma, Inc.

LYEL

Lyell Immunopharma, Inc. CEO Lynn Seely · Market cap $339.3M.

$13.80
+0.22 · +1.62%
52w hi $45.0052w lo $7.20
Off 52w high 66.7%
88
STRONG
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
4
4 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $39.50
Section 01

Recent Form 4 filings

4 filings on file
DateInsiderRoleActionSharesPriceValueScore
Nov 04ARCH Venture Fund XIII, L.P.Buy2,321,262$10.77+$25.00M88
Nov 04ARCH Venture Partners IX, LLCBuy2,321,262$10.77+$25.00M88
Mar 06ARCH Venture Partners IX, LLCBuy488,090$25.61+$12.50M86
Mar 06ARCH Venture Fund XIII, L.P.Buy488,090$25.61+$12.50M86
Section 02

Recent STOCK Act disclosures

No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03

InsiderScore history

Rolling 12 months · peak score per month
75 · STRONG60 · NOTABLE40 · ROUTINE
DecJanFebMarAprMayJunJulAugSepOctNov
/to search